Lukio Searip 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Prescription medication
HK inno.N Co., Ltd.
MFDS item code 201603071 · Approved 2016.05.30 · Insurance code 640007001
Prevention of asthma and relief of allergic rhinitis symptoms
This medication is used to prevent asthma attacks and to provide ongoing treatment for asthma. It also helps alleviate symptoms of seasonal and perennial allergic rhinitis.
This medication is taken once daily. In asthma patients, it is to be taken in the evening. In allergic rhinitis patients, dosing time is determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take it once daily, 1 tablet, 1 packet, or 1 dose in the evening. The 4 mg granules can be taken directly orally or mixed with a small amount of soft food like room-temperature purees, breast milk, or porridge. Packet
Children aged 2 to 5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months to less than 2 years: Administer 4 mg of this medication orally in the evening once daily. Infants aged 6 months to less than 2 years: 1
This medication contains the artificial sweetener aspartame, so it is important not to use it in patients with a genetic disorder called phenylketonuria. The aspartame in this medicine is broken down into phenylalanine in the body, so it should not be administered to patients who need to limit their intake of phenylalanine. Patients should also take care not to exceed the daily allowable intake of aspartame, which should not exceed 2.4 grams per day for adults. Those with hypersensitivity to this medication should not use it, and it contains lactose, so patients with lactose intolerance or related genetic disorders should also refrain from taking it. This medication is not for use during acute asthma attacks, and appropriate emergency medications should always be prepared during acute symptoms. When reducing the dose of inhaled corticosteroids, adjustments should be made gradually, following the doctor's instructions, and not suddenly. During the use of this medication, neuropsychiatric symptoms, such as restlessness, anxiety, depression, and hallucinations may occur, and patients should inform their doctor of any such changes. Do not use this medication alone to treat exercise-induced bronchospasm, and inhaled β-agonists should be used as needed. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid using these medications while taking this medication. In rare cases among asthma patients, eosinophilia and vasculitis may occur, so physicians should carefully monitor the patient's condition. No significant interactions have been reported when this medication is used with other medications, but monitoring by a doctor may be necessary when used in combination with certain drugs. Pregnant or nursing women should consult a doctor before taking this medication, as no major abnormalities were noted in animal studies, but safety in humans has not been fully established. It is also available for use in children and the elderly, but safety and efficacy have not been established in children under 6 months or patients with allergic rhinitis under 6 months of age. There is no specific antidote for overdose, so general treatment and monitoring based on symptoms are necessary, and severe symptoms require immediate medical attention. This medication is sensitive to light, so it should be opened just before use, taken immediately after preparation, and stored out of reach of children. Finally, this medication should be taken continuously even when asthma symptoms are absent, and if symptoms worsen or abnormal symptoms appear, medical consultation should be sought immediately.
Hives, angioedema, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe swelling (edema), cold sweat, pallor, severe allergic reactions, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, respiratory problems, jaundice (yellowing of the skin or eyes), extreme lethargy, liver abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication should be protected from moisture and light, and stored at room temperature between 1°C and 30°C. It is also important to keep it in a tightly closed container to prevent air exposure.
Homogeneous white granules without impurities
28 packets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Prescription medication
HK inno.N Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.